PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are United Therapeutics stock at 6.29%, Illumina at 5.54%, Regeneron Pharmaceuticals at 4.95%, Alnylam Pharmaceuticals at 4.93%, and Incyte at 4.84%.

Total Holdings

Top 10 Percentage

47.48%

Asset Class

Equity

ETF Category

Health

Assets

256.29M

PE Ratio

17.97

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	UTHR	United Therapeutics Corporation	6.29%	27,212
2	ILMN	Illumina, Inc.	5.54%	104,832
3	REGN	Regeneron Pharmaceuticals, Inc.	4.95%	16,684
4	ALNY	Alnylam Pharmaceuticals, Inc.	4.93%	38,706
5	INCY	Incyte Corporation	4.84%	127,499
6	GILD	Gilead Sciences, Inc.	4.81%	87,264
7	AMGN	Amgen Inc.	4.68%	33,651
8	BIIB	Biogen Inc.	4.63%	66,025
9	BCRX	BioCryst Pharmaceuticals, Inc.	3.50%	923,458
10	PTGX	Protagonist Therapeutics, Inc.	3.32%	80,415
11	CDNA	CareDx, Inc.	3.26%	365,065
12	TGTX	TG Therapeutics, Inc.	3.14%	230,335
13	CPRX	Catalyst Pharmaceuticals, Inc.	2.99%	290,513
14	RPRX	Royalty Pharma plc	2.99%	154,791
15	ARWR	Arrowhead Pharmaceuticals, Inc.	2.99%	110,374
16	PTCT	PTC Therapeutics, Inc.	2.91%	101,877
17	TECH	Bio-Techne Corporation	2.79%	122,004
18	EXEL	Exelixis, Inc.	2.75%	155,682
19	NBIX	Neurocrine Biosciences, Inc.	2.74%	53,660
20	HALO	Halozyme Therapeutics, Inc.	2.65%	99,880
21	RGEN	Repligen Corporation	2.64%	52,183
22	VCYT	Veracyte, Inc.	2.59%	196,903
23	VCEL	Vericel Corporation	2.47%	183,726
24	IONS	Ionis Pharmaceuticals, Inc.	2.46%	82,240
25	TBPH	Theravance Biopharma, Inc.	2.46%	368,704

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Apr 16, 2026